NCT01005745 2025-12-19
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
Clinical Trials
9 trialsNCT00975520 2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA Completed
NCT02977052 2023-11-15
OpACIN-neo
The Netherlands Cancer Institute
Phase 2 Unknown
NCT05402059 2022-06-15
ISABELLA
MelanomaPRO, Russia
Unknown
NCT04493723 2020-07-30
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The Christie NHS Foundation Trust
Recruiting
NCT00707161 2017-03-31
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
University of Utah
Phase 2 Terminated
NCT02061007 2016-05-09
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT00004022 2013-04-05
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT01013623 2012-09-26
STG4SURG
Saint John's Cancer Institute
Phase 3 Terminated